Thus, the association between increased expression of CD44 and tumor aggressiveness (including chemoresistance) could simply reflect the role that the hyaluronan/CD44 axis plays in the maintenance and self-renewal capacity of CSC populations. The gene discussed is CD44; the disease is neoplasm.